Shanghai Labway Clinical Laboratory Co

Shanghai Labway Clinical Laboratory Co Net Margin

The Net Profit Margin of Shanghai Labway Clinical Laboratory Co (301060.SZ) as of Nov 2, 2026 is -2.12 %. In the previous year, Net Profit Margin was -6.28 % — a change of -66.20% (higher).

Net Margin

-2.12 %

YoY

-66.20%

Last updated:

Net Profit Margin of Shanghai Labway Clinical Laboratory Co is 2025 -2.12 % . Net Profit Margin of Shanghai Labway Clinical Laboratory Co was 2024 -6.28 % . It decreases by -66.20% higher compared to the previous year.

Shanghai Labway Clinical Laboratory Co's net margin stands at -2.1%, down from 11.5% several years earlier.

The Shanghai Labway Clinical Laboratory Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
6.97 CNY
Jan 1, 2019
8.00 CNY
Jan 1, 2020
8.91 CNY
Jan 1, 2021
11.46 CNY
Jan 1, 2022
14.70 CNY
Jan 1, 2023
-8.46 CNY
Jan 1, 2024
-6.28 CNY
Jan 1, 2025
-2.12 CNY
The Shanghai Labway Clinical Laboratory Co Net Margin history
YEARNet MarginYoY
-2.12 %-66.20%
-6.28 %-25.72%
-8.46 %-157.52%
14.70 %+28.25%
11.46 %+28.58%
8.91 %+11.47%
8.00 %+14.71%
6.97 %+902.71%
0.70 %-90.48%
7.30 %-46.01%
13.53 %+4.05%
13.00 %+7,032.23%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Labway Clinical Laboratory Co Stock analysis

What does Shanghai Labway Clinical Laboratory Co do? Shanghai Labway Clinical Laboratory Co., Ltd. generates revenue through medical and pathological examination services, including pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination, and physical and chemical examination. The company also sells in vitro diagnostic instruments, reagents, and related accessories and consumables. Its primary customers are healthcare providers and medical institutions requiring diagnostic services and diagnostic products. The business segments are medical testing services and in vitro diagnostic product sales. The company's medical testing services cater to hospitals and clinics seeking comprehensive diagnostic solutions, while the in vitro diagnostic product sales target healthcare facilities needing equipment and supplies for laboratory operations. These services and products are provided to clients across China, focusing on the healthcare sector's demand for accurate and timely diagnostic capabilities. Shanghai Labway's revenue streams are derived from both service fees for examinations and sales of diagnostic instruments and reagents. The company's offerings align with the growing need for advanced medical diagnostics in China's expanding healthcare market, serving a broad client base within the medical industry. Shanghai Labway Clinical Laboratory Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Labway Clinical Laboratory Co stock

Net Profit Margin of Shanghai Labway Clinical Laboratory Co is -2.12 % in 2025.

Net Profit Margin of Shanghai Labway Clinical Laboratory Co changed from -6.28 % to -2.12 %, representing a -66.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Shanghai Labway Clinical Laboratory Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Shanghai Labway Clinical Laboratory Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Shanghai Labway Clinical Laboratory Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Shanghai Labway Clinical Laboratory Co